inFlow Inventory launches lot number and expiry date tracking
Small manufacturers and distributors in food, beverage, pharmaceutical and medical device industries can now trace any batch from receipt to customer, at a fraction of the cost of an enterprise ERP. TORONTO, Aug. 21, 2026 /PRNewswire/ -- inFlow Inventory has launched lot number and expiry date tracking,...
Zylox-Tonbridge Delivers Strong First-Half 2026 Results as International Revenue Surges 349%
Revenue rose 31.1% to RMB 632 million, while net profit increased 47.8% to RMB 179 million HANGZHOU, China, Aug. 20, 2026 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190, "Zylox-Tonbridge" or the "Company") today announced its interim results for the six months ended June 30, 2026. In the...
Apollo Hospitals launches ‘Always Open, Always Here’, a global first in healthcare from India
NEW DELHI, Aug. 20, 2026 /PRNewswire/ -- Apollo Hospitals launched 'Always Open. Always Here.', a first-of-its-kind initiative that makes routine and planned healthcare services available across all seven days of the week, including Sundays. Dr. M Srinivasan, Member, Niti Aayog, inaugurates the Apollo Always Open Always Here initiative in...
Ping An Reports 1H 2026 Results
Operating Profit Grows 8.3% YoY; Net Profit Surges 36.1% YoY; Interim Dividend Increases 3.2% YoY HONG KONG and SHANGHAI, Aug. 20, 2026 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. ("Ping An" or the "Group", HKEX: 2318; SSE: 601318) today announced its 2026 interim results for the six month period ended 30 June 2026. Despite...
Matwings Demonstrates Closed-Loop Protein AI Through Four AI-Wet Lab Cycles and 222 Protein Variants
The GenSci148 program illustrates a shift from one-time mutation prediction to iterative protein engineering under real drug-development constraints SHANGHAI, Aug. 20, 2026 /PRNewswire/ -- Shanghai Matwings Technology Co., Ltd. ("Matwings") today announced that GenSci148 Injection, an investigational ophthalmic biologic developed by Changchun GeneScience Pharmaceutical Co., Ltd. ("GenSci"), has received clinical trial clearance in China for neovascular age-related macular...
ISoOR 2026 Organoid Clinical Transformation Summit convened in Hangzhou
ICORE launched; nine companies joined as founding members HANGZHOU, China, Aug. 20, 2026 /PRNewswire/ -- On August 18, the International Society of Organoid Research (ISoOR) held its 2026 Organoid Clinical Transformation Summit in Hangzhou. Under the theme "From Biological Models to Credible Evidence — Standardization and Clinical Practice of Organoids," the event brought together leaders from academia, clinical medicine, industry...
Australian-first roadmap calls for national reform to protect people and pets from family violence
Led by Lucy's Project and supported by the Petstock Foundation, the National Roadmap for Change aims to ensure victim-survivors can seek safety without leaving their pets behind CANBERRA, Australia, Aug. 20, 2026 /PRNewswire/ -- A new National Roadmap for Change to Prevent and End Family Violence against People and Animals launched on 19 August, delivering an Australian-first framework...
Telix 2026 Half-Year Results: Strong Commercial Execution and Momentum in Late-Stage Pipeline
MELBOURNE, Australia and INDIANAPOLIS, Aug. 20, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces its financial results for the period ended June 30, 2026. H1 2026 key results Group performance: Double-digit revenue growth and gross margin improvement Group revenue of US$477 million, up 22%...
Pillar Biosciences, LC-SCRUM-Asia and LSI Medience Announce Liquid Biopsy Screening Collaboration in Lung Cancer
oncoReveal® Essential+ validated at LSI Medience for cfDNA/cfRNA screening in the LC-SCRUM-Asia project, with testing planned to begin in August 2026 NATICK, Mass. and TOKYO, Aug. 20, 2026 /PRNewswire/ -- Pillar Biosciences, Inc. ("Pillar"), LC-SCRUM-Asia and LSI Medience Corporation ("LSI Medience") today announced a collaboration to...
Dubai Police Initiatives Drive $176.4 Million in Social Value and Gains in Safety, Wellbeing and the Economy, Study Reveals
DUBAI, UAE, Aug. 19, 2026 /PRNewswire/ -- A study has estimated the Social Return on Investment (SROI) of 80 Dubai Police community initiatives at AED 647.9 million ($176.4 million), reflecting the wider social, economic and security value created for 3.8 million beneficiaries between 2017 and 2026. Dubai Police Initiatives Drive $176.4 Million in Social Value and Gains in...
